A detailed history of Rhumbline Advisers transactions in Lensar, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 500 shares of LNSR stock, worth $2,220. This represents 0.0% of its overall portfolio holdings.

Number of Shares
500
Previous 537 6.89%
Holding current value
$2,220
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024

SELL
$3.0 - $4.88 $111 - $180
-37 Reduced 6.89%
500 $2,000
Q2 2023

Aug 08, 2023

BUY
$2.3 - $4.34 $1,235 - $2,330
537 New
537 $2,000
Q2 2021

Aug 05, 2021

SELL
$6.87 - $8.66 $111,768 - $140,889
-16,269 Closed
0 $0
Q1 2021

May 06, 2021

SELL
$6.28 - $9.56 $1,268 - $1,931
-202 Reduced 1.23%
16,269 $118,000
Q4 2020

Feb 10, 2021

BUY
$6.7 - $12.2 $110,355 - $200,946
16,471 New
16,471 $119,000

Others Institutions Holding LNSR

About LENSAR, Inc.


  • Ticker LNSR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 11,021,000
  • Market Cap $48.9M
  • Description
  • LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in...
More about LNSR
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.